
Article content
A Kingston organization is assisting with a clinical trial to examine the effects of the psychedelic compound psilocybin on the mental health of front-line health-care providers.
Advertisement 2
Article content
Neuma Centre for Social Wellness, Kingston’s first legal psychedelic community health facility, will help administer the ATMA Journey Centers Inc. trial, which is looking to include 500 participants across Canada.
Article content
It’s the largest psilocybin clinical trial in the world to date, Cory Firth, co-creator and community director with Neuma Centre, told the Whig-Standard.
“It’s a pretty historic trial that